Investigation launched into medicinal cannabis doctors following patient suicide – Proactive Investors USA

Pharma & Biotech
Sustainability
Cannabis
Battery Metals
Artificial Intelligence
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You understand that the Content on the Site is provided for information purposes only, and none of the information contained on the Site constitutes an offer, solicitation or recommendation to buy or sell a security. You understand that the Company receives either monetary or securities compensation for our services. We stand to benefit from any volume which any Content on the Site may generate. You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value, suitability or profitability of any particular security, portfolio of securities, transaction, investment, investment strategy, or other matter. You understand…
Read more
Proactive financial news and online broadcast teams provide fast, accessible, informative and actionable business and finance news content to a global investment audience. All our content is produced independently by our experienced and qualified teams of news journalists.
Proactive news team spans the world’s key finance and investing hubs with bureaus and studios in London, New York, Toronto, Vancouver, Sydney and Perth.
We are experts in medium and small-cap markets, we also keep our community up to date with blue-chip companies, commodities and broader investment stories. This is content that excites and engages motivated private investors.
The team delivers news and unique insights across the market including but not confined to: biotech and pharma, mining and natural resources, battery metals, oil and gas, crypto and emerging digital and EV technologies.
Proactive has always been a forward looking and enthusiastic technology adopter.
Our human content creators are equipped with many decades of valuable expertise and experience. The team also has access to and use technologies to assist and enhance workflows.
Proactive will on occasion use automation and software tools, including generative AI. Nevertheless, all content published by Proactive is edited and authored by humans, in line with best practice in regard to content production and search engine optimisation.
Published: 21:30 10 Oct 2024 EDT
The pharmacist who founded Australia’s first subscription-based medicinal cannabis platform, Dispensed, has been banned from supplying cannabis and a further two doctors have been suspended as authorities launch an investigation into a man’s death, and alleged inappropriate prescribing to another patient.
The New South Wales coroner is preparing a report into the death of the 41-year-old, who had a pre-existing mental health condition exacerbated by medicinal cannabis prescribed through Dispensed. 
Despite his history of hallucinations and psychosis, the deceased received continued cannabis deliveries after his death was reported to the platform by his family.
According to Professor Brett Emmerson, chair of the Queensland branch of the Royal Australian and New Zealand College of Psychiatrists, it is inappropriate to prescribe medicinal cannabis to any patient with a history of psychosis or schizophrenia.
Emmerson said, “One of the most common causes, over many years as a psychiatrist, of people (with schizophrenia) relapsing is the fact that they get their hands on THC.”
The father of the deceased man expressed dismay over the ease with which cannabis was prescribed, circumventing his son’s regular medical providers.
In a separate incident, as revealed by an ABC investigation, a 31-year old patient diagnosed with schizophrenia received cannabis despite warnings from his mother. This led to a severe deterioration in mental health, culminating in hospitalisation under involuntary treatment.
Concerns have been raised over the regulatory oversight of telehealth platforms like Dispensed, where prescriptions are issued remotely without adequate checks. 
Sign up to receive alerts and news direct to your inbox
Proactive’s Tylah Tully breaks down 'Just the Facts' of the latest news from Kinetiko Energy Ltd (ASX:KKO, OTC:KKOEF). Kinetiko is advancing its shallow conventional gas projects in South Africa, focusing on reducing the country’s reliance on coal and imported energy. The company's…
Copyright © Proactive Group Holdings Inc, 2024
All Rights Reserved – Proactive North America Inc., Proactive Investors LLC.
Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use.

source